A 18F-FDG PET/CT based radiomics nomogram for predicting disease-free survival in stage II/III colorectal adenocarcinoma
- 3 August 2024
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (1) , 64-77
Abstract
Objectives This study aimed to establish a clinical nomogram model based on a radiomics signatures derived from 18F-fluorodeoxyglucose positron-emission tomography (18F-FDG PET/CT) and clinical parameters to predict disease-free survival (DFS) in patients with stage II/III colorectal adenocarcinoma. Understanding and predicting DFS in these patients is key to optimizing treatment strategies. Methods A retrospective analysis included 332 cases from July 2011 to July 2021 at The Sixth Affiliated Hospital, Sun Yat-sen University, with PET/CT assessing radiomics features and clinicopathological features. Univariate Cox regression, the least absolute shrinkage and selection operator (LASSO) Cox, and multivariable Cox regression identified recurrence-related radiomics features. We used a weighted radiomics score (Rad-score) and independent risk factors to construct a nomogram. Evaluation involved time-dependent receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Results The nomogram, incorporating Rad-score, pN, and pT demonstrated robust predictive ability for DFS in stage II/III colorectal adenocarcinoma. Training cohort areas under the curve (AUCs) were 0.78, 0.80, and 0.86 at 1, 2, and 3 years, respectively, and validation cohort AUCs were 0.79, 0.75, and 0.73. DCA and calibration curves affirmed the nomogram’s clinical relevance. Conclusion The 18F-FDG PET/CT based radiomics nomogram, including Rad-score, pN, and pT, effectively predicted tumor recurrence in stage II/III colorectal adenocarcinoma, significantly enhancing prognostic stratification. Our findings highlight the potential of this nomogram as a guide for clinical decision making to improve patient outcomes.Keywords
Funding Information
- Natural Science Foundation of Xinjiang Uygur Autonomous Region (No.2021D01F16)
- National Natural Science Foundation of China (No.81901772)
- Natural Science Foundation of Guangdong Province (No.2019A1515011893, 2023A1515011300)
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia&The First People’s Hospital of Kashi Fund (No.SKL-HIDCA-2020-KS2)
- Program of Guangdong Provincial Clinical Research Center for Digestive Diseases (No.2020B1111170004)
This publication has 40 references indexed in Scilit:
- Copy‐number intratumor heterogeneity increases the risk of relapse in chemotherapy‐naive stage II colon cancerThe Journal of Pathology, 2022
- The survival after recurrence of colorectal cancer: a retrospective study focused on time to recurrence after curative resectionSurgery Today, 2021
- Prediction of recurrence after surgery in colorectal cancer patients using radiomics from diagnostic contrast-enhanced computed tomography: a two-center studyEuropean Radiology, 2021
- Prognostic and predictive value of radiomics signatures in stage I‐III colon cancerClinical and Translational Medicine, 2020
- Radiomics in Oncological PET/CT: a Methodological OverviewNuclear Medicine and Molecular Imaging, 2019
- FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancerJournal of Surgical Oncology, 2017
- Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010JAMA Surgery, 2015
- Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival?International Journal of Colorectal Disease, 2013
- Postoperative Adjuvant Chemotherapy for Stage II Colorectal Cancer: A Systematic Review of 12 Randomized Controlled TrialsJournal of Gastrointestinal Surgery, 2012